Table 5.
Univariate and multivariate analyses of factors affecting relapse-free survival after surgery
Univariate |
Multivariate |
|||
HR (95%CI) | P value | HR (95%CI) | P value | |
Age (over 65 years old) | 0.81 | 0.8640 | 0.84 | 0.6300 |
(0.47-1.43) | (0.42-1.68) | |||
CEA ≥ 3.85 ng/mL | 1.28 | 0.0827 | 1.12 | 0.7360 |
(0.72-2.28) | (0.57-2.19) | |||
CA19-9 ≥ 56.8 U/mL | 2.58 | 0.0030 | 2.34 | 0.0798 |
(1.43-4.82) | (1.14-4.92) | |||
Tumor size (> 20 mm) | 1.67 | 0.2420 | 3.31 | 0.0254 |
(0.92-2.28) | (1.15-10.3) | |||
Portal vein invasion | 2.12 | 0.0123 | 0.61 | 0.2752 |
(1.18-3.78) | (0.24-1.47) | |||
UICC ≥ IIB | 2.44 | 0.0016 | 1.97 | 0.0588 |
(1.39-4.42) | (0.98-4.16) | |||
R1/R0 | 1.98 | 0.2590 | 1.96 | 0.4266 |
(0.32-6.54) | (0.29-7.60) | |||
Adjuvant chemotherapy | 0.78 | 0.2040 | 0.43 | 0.0168 |
(0.44-1.40) | (0.22-0.85) | |||
EUS-FNA | 0.5 | 0.0150 | 0.46 | 0.0606 |
(0.29-0.87) | (0.20-1.03) |
UICC: Pathological stage of the Union Internationale Contre le Cancer; EUS-FNA: Endoscopic ultrasound-guided fine-needle aspiration.